跳至主要内容
临床试验/CTRI/2019/07/019964
CTRI/2019/07/019964进行中(未招募)4 期

A Prospective , Randomized , Open Label Study To Evaluate The Efficacy And Safety Of Systemic Terbinafine And Topical Amorolfine Compared to Systemic Itraconazole And Topical Amorolfine In Adult Patients Of Recalcitrant Tinea Cruris

Dr Vasudha Sharma0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients with recalcitrant Tinea Cruris
  • 2. Patients willing to give informed consent and comply with the treatment and follow up

排除标准

  • 1. <18 years and > 65 years age
  • 2. Pregnant or Lactating women
  • 3. Secondary bacterial infections
  • 4. Deep mycosis
  • 5. Immunocompromised patients- Severe uncontrolled Diabetes, HIV/AIDS, chronic glucocorticoid therapy
  • 6. Patients with abnormal liver function and kidney function test
  • 7. Present or past history of malignancy
  • 8. Patients with known history of allergy to Itraconazole or Terbinafine or related drugs
  • 9. patients with history of ischemic heart disease
  • 10. Patients not giving informed consent

研究者

发起方
Dr Vasudha Sharma

相似试验